Acupuncture FAQ`s - Laramie Peak Veterinary
... your goals, the condition being treated, and the animal's response to treatment. When treating health disorders, a typical treatment regimen consists of an initial period of weekly treatments that are eventual ...
... your goals, the condition being treated, and the animal's response to treatment. When treating health disorders, a typical treatment regimen consists of an initial period of weekly treatments that are eventual ...
Migraine - University of Washington
... “My dilaudid only works IV and only if I get at least 8mg at once.” “I have to get benadryl with it or I get itchy – I need 50mg… It has to be IV.” “I’m sooo nauseated too. I’m allergic to all the anti-nausea medications except IV ...
... “My dilaudid only works IV and only if I get at least 8mg at once.” “I have to get benadryl with it or I get itchy – I need 50mg… It has to be IV.” “I’m sooo nauseated too. I’m allergic to all the anti-nausea medications except IV ...
Management of Acute Asthma Exacerbations
... inhalations of short-acting beta2 agonists 20 minutes apart followed by a reassessment of peak expiratory flow and symptoms may be safely employed at home. Administration using a hand-held metered-dose inhaler with a spacer device is at least equivalent to nebulized beta2 agonist therapy in children ...
... inhalations of short-acting beta2 agonists 20 minutes apart followed by a reassessment of peak expiratory flow and symptoms may be safely employed at home. Administration using a hand-held metered-dose inhaler with a spacer device is at least equivalent to nebulized beta2 agonist therapy in children ...
Targeted interventions for difficult-to-treat asthma
... the use of biomarkers to assess control, are discussed. Newer and developing therapies that cater to specific types of asthmatic patients and may lead to improved outcomes in those patients for whom standard care is insufficient are also looked at. Keywords: asthma control, biomarker, difficult asth ...
... the use of biomarkers to assess control, are discussed. Newer and developing therapies that cater to specific types of asthmatic patients and may lead to improved outcomes in those patients for whom standard care is insufficient are also looked at. Keywords: asthma control, biomarker, difficult asth ...
Diagnosis and Management of Osteonecrosis of the Jaw: A
... beyond the confines of the alveolar bone. The term “Stage 0” ONJ is used by AAOMS(2) to refer to any or all of these symptoms or signs in patients on antiresorptive therapy. Members of this Task Force, however, expressed concern that the use of such Stage 0 terminology may lead to overdiagnosis of ON ...
... beyond the confines of the alveolar bone. The term “Stage 0” ONJ is used by AAOMS(2) to refer to any or all of these symptoms or signs in patients on antiresorptive therapy. Members of this Task Force, however, expressed concern that the use of such Stage 0 terminology may lead to overdiagnosis of ON ...
CCR 1101-3 - Colorado Secretary of State
... should never be released to “sedentary or light duty” without specific physical limitations. The practitioner must understand all of the physical, demands of the patient’s job position before returning the patient to full duty and should request clarification of the patient’s job duties. Clarificati ...
... should never be released to “sedentary or light duty” without specific physical limitations. The practitioner must understand all of the physical, demands of the patient’s job position before returning the patient to full duty and should request clarification of the patient’s job duties. Clarificati ...
Presentation - Neuropathology
... No oligoclonal bands, normal IgG index JC virus Ab negative HSV/VZV pcr’s were negative ...
... No oligoclonal bands, normal IgG index JC virus Ab negative HSV/VZV pcr’s were negative ...
Immune-Mediated Adverse Reactions Management Guide
... This section contains guidance for the management of select immune-mediated adverse reactions, which includes adverse reaction management algorithms from the clinical trials of OPDIVO.1,2 For ease of use, this guidance is organized by body system and contains both management and follow-up informatio ...
... This section contains guidance for the management of select immune-mediated adverse reactions, which includes adverse reaction management algorithms from the clinical trials of OPDIVO.1,2 For ease of use, this guidance is organized by body system and contains both management and follow-up informatio ...
VELCADE® (bortezomib) frequently asked questions
... untreated multiple myeloma? For patients who were not eligible for a stem cell transplant, a clinical trial compared VELCADE (bortezomib) in combination with 2 drugs, melphalan and prednisone (MP), versus MP alone. There were 682 patients involved in this study, all of whom had not been treated • At ...
... untreated multiple myeloma? For patients who were not eligible for a stem cell transplant, a clinical trial compared VELCADE (bortezomib) in combination with 2 drugs, melphalan and prednisone (MP), versus MP alone. There were 682 patients involved in this study, all of whom had not been treated • At ...
Infectious Diseases Society of America/American Thoracic Society
... level, 120 mg/dL; leukopenia resulting from infection; thrombocytopenia; hypothermia; or hypotension requiring aggressive fluid resuscitation) is proposed (table 4). The presence of at least 3 of these criteria suggests the need for ICU care but will require prospective validation. ...
... level, 120 mg/dL; leukopenia resulting from infection; thrombocytopenia; hypothermia; or hypotension requiring aggressive fluid resuscitation) is proposed (table 4). The presence of at least 3 of these criteria suggests the need for ICU care but will require prospective validation. ...
Neuro Board Review
... The first step in the diagnostic process is to localize the problem to the proper level of the nervous system: brain, brainstem/cerebellum, spinal cord, nerve, junction, or muscle. Such a determination not only allows for urgent appropriate diagnosis and treatment but can reduce unnecessary discomfo ...
... The first step in the diagnostic process is to localize the problem to the proper level of the nervous system: brain, brainstem/cerebellum, spinal cord, nerve, junction, or muscle. Such a determination not only allows for urgent appropriate diagnosis and treatment but can reduce unnecessary discomfo ...
Biaxin® XL / Biaxin
... BIAXIN Filmtab and BIAXIN Granules are indicated in pediatric patients for the treatment of mild to moderate infections caused by susceptible isolates due to Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniae [see Clinical Studies (14.2)]. 1.7 Treatment and Prophylaxis of Dis ...
... BIAXIN Filmtab and BIAXIN Granules are indicated in pediatric patients for the treatment of mild to moderate infections caused by susceptible isolates due to Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniae [see Clinical Studies (14.2)]. 1.7 Treatment and Prophylaxis of Dis ...
1: Introduction and Summary
... health. The use of apheresis has been generally acknowledged as an effective treatment application for acute therapy in a small group of relatively obscure diseases. These include acquired myasthenia gravis, primary macroglobulinemia (Waldenstrom’s) and hyperglobulinemias, including multiple myeloma ...
... health. The use of apheresis has been generally acknowledged as an effective treatment application for acute therapy in a small group of relatively obscure diseases. These include acquired myasthenia gravis, primary macroglobulinemia (Waldenstrom’s) and hyperglobulinemias, including multiple myeloma ...
Rituximab-Associated Infections
... of JC in the cerebrospinal fluid [CSF]). Most cases are diagnosed by PCR, but the sensitivity of this test may be as low as 75% and brain biopsy may be required. Most patients with rituximab-related PML were receiving this agent as part of the treatment regimen for hematologic malignancy, and had re ...
... of JC in the cerebrospinal fluid [CSF]). Most cases are diagnosed by PCR, but the sensitivity of this test may be as low as 75% and brain biopsy may be required. Most patients with rituximab-related PML were receiving this agent as part of the treatment regimen for hematologic malignancy, and had re ...
Journal of Pediatric Critical Care
... Aggarwal et al was awarded best paper “Hansraj memorial award”. This should be a trigger factor for all the young and enthusiastic fellows and faculty persuing the carrier of Pediatric critical care medicine, to systematically study, collate, analyse and publish many important issues that deserve du ...
... Aggarwal et al was awarded best paper “Hansraj memorial award”. This should be a trigger factor for all the young and enthusiastic fellows and faculty persuing the carrier of Pediatric critical care medicine, to systematically study, collate, analyse and publish many important issues that deserve du ...
Limitations of Trauma-Focused Therapies for Treating
... repeated until subjective distress disappears. Afterward, a positive cognitive is provided to replace the previously spontaneous negative cognition and the dual task is applied again to implement the chosen positive cognition. The process is repeated until the positive cognition is ...
... repeated until subjective distress disappears. Afterward, a positive cognitive is provided to replace the previously spontaneous negative cognition and the dual task is applied again to implement the chosen positive cognition. The process is repeated until the positive cognition is ...
homeopathy - Medical Clinics of North America
... Principle of Similars The principle of similars suggests that one can ameliorate a disease process using a dilute form of a substance that can induce the same symptoms in the patient when healthy.19 This is in contrast to allopathy (from Greek, allo, meaning opposite, and pathos, meaning suffering), ...
... Principle of Similars The principle of similars suggests that one can ameliorate a disease process using a dilute form of a substance that can induce the same symptoms in the patient when healthy.19 This is in contrast to allopathy (from Greek, allo, meaning opposite, and pathos, meaning suffering), ...
View - Auro Pharma Inc
... preparation should be considered. Close monitoring of cardiac function for not less than five days is advisable. Anticonvulsants may be given to control seizures. Dialysis is probably of no value because of low plasma concentrations of the drug. Since overdosage is often deliberate, patients may at ...
... preparation should be considered. Close monitoring of cardiac function for not less than five days is advisable. Anticonvulsants may be given to control seizures. Dialysis is probably of no value because of low plasma concentrations of the drug. Since overdosage is often deliberate, patients may at ...
Vulvar Disease Clinical Cases Information
... Acitretin (Soriatane) .It can work well in low dose 30-70 mg/week. ( Isotretinoin has been used to treat oral lichen planus; however, discontinuation of the medication results in recurrence of the oral lesions.) Long-term use of retinoids may result in liver dysfunction.but not in the small doses re ...
... Acitretin (Soriatane) .It can work well in low dose 30-70 mg/week. ( Isotretinoin has been used to treat oral lichen planus; however, discontinuation of the medication results in recurrence of the oral lesions.) Long-term use of retinoids may result in liver dysfunction.but not in the small doses re ...
advicor - Sunovion Pharmaceuticals Canada Inc.
... stopped for a few days before elective major surgery and when any major acute medical or surgical condition supervenes. If ADVICOR therapy is discontinued for an extended period, reinstitution of therapy should include a titration period. The risk of adverse muscle events with statins is dose relate ...
... stopped for a few days before elective major surgery and when any major acute medical or surgical condition supervenes. If ADVICOR therapy is discontinued for an extended period, reinstitution of therapy should include a titration period. The risk of adverse muscle events with statins is dose relate ...
differentiating copd and asthma - Ohio Association of Physician
... involve some similar medications (anti-inflammatories). While the commonalities are significant, the differences help us understand that these are not the same diseases even if they share some qualities. While they are both labeled as “chronic”, which seems obvious in COPD though less so in asthma, ...
... involve some similar medications (anti-inflammatories). While the commonalities are significant, the differences help us understand that these are not the same diseases even if they share some qualities. While they are both labeled as “chronic”, which seems obvious in COPD though less so in asthma, ...
6 Management of Hepatitis C and HIV Coinfection
... Low percentages (0–23%) of coinfected patients have access to hepatitis C treatment (22). There may be several reasons for this: • The efficacy of PEG-IFN and RBV in treating coinfected patients was only published in 2004, and these drugs are not widely available. • A great number of patients who ...
... Low percentages (0–23%) of coinfected patients have access to hepatitis C treatment (22). There may be several reasons for this: • The efficacy of PEG-IFN and RBV in treating coinfected patients was only published in 2004, and these drugs are not widely available. • A great number of patients who ...
File - Lauren VanDalsum
... causing more harm than good. Additional articles go on to discuss aromatherapy as part of the CAM “umbrella,” some even going as far as calling the entire practice of CAM “quackery” and “pseudoscience.” In his article, “Quackademic medicine trickles out to community hospitals,” David Gorski, MD, PhD ...
... causing more harm than good. Additional articles go on to discuss aromatherapy as part of the CAM “umbrella,” some even going as far as calling the entire practice of CAM “quackery” and “pseudoscience.” In his article, “Quackademic medicine trickles out to community hospitals,” David Gorski, MD, PhD ...
applied - University of Washington
... AB: In spite of many available studies on bleomycin and cryotherapy in treating warts, little head to head research is done to compare efficacy of these treatments. Our aim was to compare the therapeutic effects of intralesional bleomycin and cryotherapy on common warts of the hands and feet. In thi ...
... AB: In spite of many available studies on bleomycin and cryotherapy in treating warts, little head to head research is done to compare efficacy of these treatments. Our aim was to compare the therapeutic effects of intralesional bleomycin and cryotherapy on common warts of the hands and feet. In thi ...
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS)
... even without treatment11.b)Secondary Syphilis: Secondary syphilis is the result of hematogenous dissemination of T. Pallidum, which subsequently causes systemic symptoms. This stage typically occurs 6 to 8 weeks after the primary infection 11. Secondary syphilis is often a subtle disease; the skin l ...
... even without treatment11.b)Secondary Syphilis: Secondary syphilis is the result of hematogenous dissemination of T. Pallidum, which subsequently causes systemic symptoms. This stage typically occurs 6 to 8 weeks after the primary infection 11. Secondary syphilis is often a subtle disease; the skin l ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.